O'Shaughnessy Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
O'Shaughnessy Asset Management's RIGL Position: Q3 2026 in Review
O'Shaughnessy Asset Management increased its Rigel Pharmaceuticals (RIGL) stake by 13% in Q3 2026, buying an estimated $734K and bringing the position to 148,084 shares worth $7.6M. The position accounts for 0.03% of the portfolio, ranked #468.
O'Shaughnessy Asset Management first reported a position in RIGL in Q3 2021 and has held it in 8 quarters since. 166 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.
- O'Shaughnessy Asset Management held 148,084 shares of Rigel Pharmaceuticals worth $7.6M as of Q3 2026.
- O'Shaughnessy Asset Management bought 16,907 Rigel Pharmaceuticals shares in Q3 2026, an estimated $734K.
- Rigel Pharmaceuticals made up 0.03% of O'Shaughnessy Asset Management's portfolio in Q3 2026, its #468 holding.
- O'Shaughnessy Asset Management first reported a position in Rigel Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
- 166 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.